Q11677 (Q11677): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
39,804,511.31 Czech koruna
| |||||||||||||||
| Property / EU contribution: 39,804,511.31 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
1,592,180.4524 Euro
| |||||||||||||||
| Property / EU contribution: 1,592,180.4524 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution: 1,592,180.4524 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / EU contribution: 1,592,180.4524 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
| Property / budget | |||||||||||||||
61,769,881.0 Czech koruna
| |||||||||||||||
| Property / budget: 61,769,881.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
2,470,795.24 Euro
| |||||||||||||||
| Property / budget: 2,470,795.24 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / budget: 2,470,795.24 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / budget: 2,470,795.24 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
Revision as of 01:34, 12 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project in Czech Republic financed by DG Regio |
Statements
39,804,511.31 Czech koruna
0 references
61,769,881.0 Czech koruna
0 references
64.439999989639 percent
0 references
31 October 2020
0 references
Institute of Applied Biotechnologies a.s.
0 references
50°5'1.93"N, 14°30'28.48"E
0 references
10800
0 references
10800
0 references
Jedná se o projekt vysoké technologické úrovně a vysoké míry inovace, který si klade za cíl významně zvýšit produktový potenciál společnosti Institute of Applied Biotechnologies a.s. (IAB) ve spolupráci s výzkumným partnerem Lékařskou fakultou Univerzity Palackého v Olomouci, jmenovitě Ústavem molekulární a translační medicíny (UMTM). Cílem je vývoj produktů pro prediktivní onkologickou diagnostiku založenou na cirkulujících buňkách / DNA / RNA. a. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/17_107/0012422
0 references